Study of TAK-228 (MLN0128) in Soft Tissue Sarcomas

NCT02987959 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

6

Enrollment

OTHER

Sponsor class

Stopped Closed to accrual due to Funding Sponsor withdrawing support due to low accrual

Conditions

Soft-tissue Sarcoma

Interventions

DRUG: TAK-228

Sponsor

Fox Chase Cancer Center